Karen Parkhill - Medtronic PLC CFO, Executive Vice President
| 2M6 Stock | EUR 77.10 0.17 0.22% |
President
Ms. Karen L. Parkhill is an Chief Financial Officer, Executive Vice President of the Company effective June 2016. From 2011 to 2016, Ms. Parkhill served as Vice Chairman and Chief Financial Officer of Comerica Incorporated. Ms. Parkhill was a member of Comericas Management Executive Committee and the Comerica Bank Board of Directors. Prior to joining Comerica, Ms. Parkhill worked for J.P. Morgan Chase Co. in various capacities from 1992 to 2011, including serving as Chief Financial Officer of the Commercial Banking business from 2007 to 2011. Ms. Parkhill is also a current member of the Board of Directors for the Methodist Health System in Dallas. since 2016.
| Age | 58 |
| Tenure | 8 years |
| Phone | 353 1 438 1700 |
| Web | https://www.medtronic.com |
Karen Parkhill Latest Insider Activity
Tracking and analyzing the buying and selling activities of Karen Parkhill against Medtronic PLC stock is an integral part of due diligence when investing in Medtronic PLC. Karen Parkhill insider activity provides valuable insight into whether Medtronic PLC is net buyers or sellers over its current business cycle. Note, Medtronic PLC insiders must abide by specific rules, including filing SEC forms every time they buy or sell Medtronic PLC'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Karen Parkhill over three months ago Insider Trading |
Medtronic PLC Management Efficiency
The company has return on total asset (ROA) of 0.0449 % which means that it generated a profit of $0.0449 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0784 %, meaning that it generated $0.0784 on every $100 dollars invested by stockholders. Medtronic PLC's management efficiency ratios could be used to measure how well Medtronic PLC manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | PRESIDENT Age | ||
| Viju Menon | Stryker | 55 | |
| Glenn Boehnlein | Stryker | 61 | |
| William Berry | Stryker | 57 | |
| Timothy Scannell | Stryker | 58 | |
Management Performance
| Return On Equity | 0.0784 | |||
| Return On Asset | 0.0449 |
Medtronic PLC Leadership Team
Elected by the shareholders, the Medtronic PLC's board of directors comprises two types of representatives: Medtronic PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medtronic. The board's role is to monitor Medtronic PLC's management team and ensure that shareholders' interests are well served. Medtronic PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medtronic PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sean Lennon, Chief Officer | ||
| Jennifer Kirk, Global Officer | ||
| Geoffrey Martha, Executive Vice President and President - Restorative Therapies Group | ||
| Robert White, Executive Vice President and President of Medtronic’s Minimally Invasive Therapies Group | ||
| Ryan Weispfenning, Vice President - Investor Relations | ||
| Robert Hoedt, Executive Vice President and President - EMEAC | ||
| Mark Ploof, Sr Services | ||
| Ivan Fong, Gen VP | ||
| MSc MD, Medical Scientific | ||
| Karen Parkhill, CFO, Executive Vice President |
Medtronic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medtronic PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0784 | |||
| Return On Asset | 0.0449 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 113.84 B | |||
| Shares Outstanding | 1.33 B | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 84.51 % | |||
| Price To Earning | 26.98 X | |||
| Price To Book | 1.99 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Medtronic Stock
When determining whether Medtronic PLC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Medtronic Stock please use our How to Invest in Medtronic PLC guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.